Clinical Trials Logo

Status Epilepticus clinical trials

View clinical trials related to Status Epilepticus.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04309721 Terminated - Clinical trials for Epilepticus; Status, Focal Motor

Perampanel in Focal Status Epilepticus

PEPSI
Start date: November 2, 2022
Phase: Phase 3
Study type: Interventional

Randomized controlled trial on focal motor status epilepticus (SE), studying the add-on efficacy of the enteral administration of perampanel (PER) to a conventional intravenous antiepileptic drug.

NCT ID: NCT03819543 Terminated - Status Epilepticus Clinical Trials

SURESTEP: Transcranial Direct Current Stimulation in Super Refractory Status Epilepticus

SURESTEP
Start date: July 15, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether transcranial direct current stimulation affects super refractory status epilepticus.

NCT ID: NCT03154307 Terminated - Epilepsy Clinical Trials

Repeated TMS at Low Frequencies to Reduce Seizure Occurrence

Start date: February 19, 2016
Phase: N/A
Study type: Interventional

Perform non-invasive neuro-navigated repeated Transcranial Magnetic Stimulation (rTMS) at low frequencies (LF) with the intent to reduce the occurrence of seizures over time (long-term protocol). Seizure reduction and improvements in the quality of life in patients with epilepsy will be associated with increased cortical inhibition resulting from the LF-rTMS sessions over time. This procedure using rTMS at low frequencies (LF-rTMS) between 0.5 and 1 Hz is a safe and painless method for noninvasive focal cortical brain stimulation, which will be evaluated in its efficacy at reducing/suppressing seizures. Accordingly, we propose a clinical trial in patients with epilepsy to test whether LF-rTMS can improve seizure suppression. The location of the presumed 3D source in the brain will be stimulated for few minutes (10 to 15 min.). With the same rTMS modality, we will also perform motor threshold mapping in conjunction with its fully integrated and compatible electroencephalography (EEG) module. Up to 100 individuals 18 to 80 years with epilepsy will be enrolled. In addition, a short-term protocol has been added to test whether LF-rTMS can reduce or suppress status epilepticus in medically refractory participants.

NCT ID: NCT02904265 Terminated - Clinical trials for Status Epilepticus, Electrographic

Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome

Start date: September 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to compare the effectiveness of the medications acetazolamide and diazepam in the treatment of continuous spike wave in sleep (CSWS) and Landau-Kleffner syndrome (LKS).

NCT ID: NCT02560597 Terminated - Status Epilepticus Clinical Trials

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy

Start date: February 3, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effects of repetitive transcranial magnetic stimulation (rTMS) as a treatment for Epilepsia Partialis Continua (EPC) or refractory Status Epilepticus (SE), when standard clinical treatments have failed.

NCT ID: NCT02431663 Terminated - Status Epilepticus Clinical Trials

Ketamine in Refractory Convulsive Status Epilepticus

KETASER01
Start date: April 2015
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy of intravenous administration of ketamine in the treatment of refractory convulsive status epilepticus in children compared to administration of midazolam at high doses, thiopental and / or propofol.

NCT ID: NCT00343096 Terminated - Status Epilepticus Clinical Trials

Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children.

Start date: June 2006
Phase: Phase 3
Study type: Interventional

This study aims to address the hypothesis that Lorazepam (an anticonvulsant) is as effective when given via the intranasal or buccal route as the intravenous route in terminating convulsions in children.

NCT ID: NCT00265616 Terminated - Status Epilepticus Clinical Trials

Treatment of Refractory Status Epilepticus

Start date: May 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether propofol or barbiturates should be preferred in the treatment of status epilepticus (continuous seizure activity) refractory to 2 standard antiepileptic agents.